Isn't it interesting how there is big volume at this level. The level that Southridge partners agreement was estimated at for (S1 filing FEE). Someone(or group) is always willing to buy large down here. I raised my share count along with these characters, because! I believe the success of the Imenvax therapy safety studies will be the catlyst that will put this company on Centerstage of the stemcell market for vetrenarians. Looking for the results in february 2013.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.